Associations between autonomic dysfunction and pain in chemotherapy-induced polyneuropathy

Area of Science:

• Neurology
• Pain Research
• Oncology

Background:

• Autonomic neuropathy is a chemotherapy complication affecting the vagus nerve.
• This can impair pain inhibition and increase pain sensitivity.
• Chemotherapy-induced polyneuropathy (CIPN) impacts cancer patients.

Purpose of the Study:

• To investigate the link between autonomic parasympathetic function and pain perception in CIPN patients.
• To assess relationships with spontaneous, non-painful, and painful sensations.
• To understand the role of vagal function in chemotherapy-related neuropathy.

Main Methods:

• 27 cancer patients with CIPN underwent autonomic function tests (heart rate variability, deep-breathing, Valsalva ratios).
• Sensory perception was evaluated using warm, cold, and mechanical detection thresholds.
• Pain perception was measured via heat pain thresholds, suprathreshold stimulus ratings, temporal summation, and conditioned pain modulation.

Main Results:

• No association found between autonomic parameters and spontaneous pain.
• Autonomic parameters positively correlated with non-painful sensations; reduced autonomic function linked to sensory neuropathy.
• Autonomic parameters negatively correlated with painful sensations; lower parasympathetic activity associated with higher pain sensitivity.

Conclusions:

• Diminished vagal function in neuropathy is linked to pain disinhibition.
• Reduced parasympathetic activity may underlie increased experimental pain perception.
• Autonomic dysfunction contributes to altered pain processing in CIPN.